Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Enter your registration information

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Amylin Pharmaceuticals Inc. Newsletter

From Lab to Landmark Therapy: Meet the Woman Behind GLP-1 18 Jul 2025 10:46 GMT
… in lizard venom, which allowed Amylin Pharmaceuticals to act quickly since they …
Aardvark Therapeutics Bolsters Leadership Team with Strategic Hires Across Scientific, Commercial, Regulatory and Legal Functions 19 May 2025 20:10 GMT
… at Acer Therapeutics, Intercept Pharmaceuticals, Amylin Pharmaceuticals, and Gen-Probe. Dr. Kellmeyer …
BlossomHill Therapeutics Appoints Jason Keyes as Chief Financial Officer and Executive Vice President 09 May 2025 12:00 GMT
… finance and strategic planning at Amylin Pharmaceuticals, Inc., Amgen, Inc., and Baxter …
Asembia AXS25: Navigating the Transformative Landscape of GLP-1 Medications 08 May 2025 21:14 GMT
… diabetes in 2005 (exenatide; Byetta; Amylin Pharmaceuticals, Eli Lilly) and obesity (liraglutide …
GLP-1 agents ‘can help lower systemic inflammation,’ show promise in rheumatology 01 May 2025 10:49 GMT
… Lilly & Co.), exenatide (Byetta, Amylin Pharmaceuticals; and Bydureon, AstraZeneca), liraglutide (Victoza …
Daily pill may work as well as Ozempic for weight loss and blood sugar, Eli Lilly says If orforglipron is eventually approved by the Food and Drug Administration, it would become the first GLP-1 oral drug for weight loss to hit the market. Read More » 17 Apr 2025 20:05 GMT
… 2000s, Lilly partnered with biotech Amylin Pharmaceuticals to develop the first-in …

Continue to create your account.